These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3996474)

  • 1. Gallamine binding to heart M2 cholinergic receptors does not antagonize cholinergic inhibition of adenylate cyclase in isolated plasma membrane.
    Jagadeesh G; Sulakhe PV
    Eur J Pharmacol; 1985 Feb; 109(2):311-3. PubMed ID: 3996474
    [No Abstract]   [Full Text] [Related]  

  • 2. Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium.
    Dunlap J; Brown JH
    Mol Pharmacol; 1983 Jul; 24(1):15-22. PubMed ID: 6135150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscarinic M2 receptors coupled to inhibition of adenylate cyclase in rat heart.
    Wei JW; Wang MC
    Chin J Physiol; 1990; 33(4):315-27. PubMed ID: 2129026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coupling of subtypes of the muscarinic receptor to adenylate cyclase in the corpus striatum and heart.
    Ehlert FJ; Delen FM; Yun SH; Friedman DJ; Self DW
    J Pharmacol Exp Ther; 1989 Nov; 251(2):660-71. PubMed ID: 2810116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of the binding properties of muscarinic receptors by gallamine.
    Stockton JM; Birdsall NJ; Burgen AS; Hulme EC
    Mol Pharmacol; 1983 May; 23(3):551-7. PubMed ID: 6865905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE
    Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the interactions of gallamine with muscarinic receptors from brain.
    Ellis J; Lenox RH
    Biochem Pharmacol; 1985 Jun; 34(12):2214-7. PubMed ID: 4004942
    [No Abstract]   [Full Text] [Related]  

  • 8. Competitive interaction of gallamine with multiple muscarinic receptors.
    Ellis J; Hoss W
    Biochem Pharmacol; 1982 Mar; 31(5):873-6. PubMed ID: 7082354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gallamine allosterically antagonizes muscarinic receptor-mediated inhibition of adenylate cyclase activity in the rat myocardium.
    Ehlert FJ
    J Pharmacol Exp Ther; 1988 Nov; 247(2):596-602. PubMed ID: 3183955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholinergic muscarinic receptors in bovine adrenal cortex.
    Hadjian AJ; Ventre R; Chambaz EM
    Biochem Biophys Res Commun; 1981 Feb; 98(4):892-900. PubMed ID: 7225130
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of ligand choice on the apparent binding profile of gallamine to cardiac muscarinic receptors. Identification of three main types of gallamine-muscarinic receptor interactions.
    Lee NH; el-Fakahany EE
    J Pharmacol Exp Ther; 1988 Sep; 246(3):829-38. PubMed ID: 3418516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quaternary forms of classical muscarinic antagonists distinguish subpopulations of muscarinic receptors: correlation with gallamine-defined subpopulations.
    Ellis J; Lenox RH
    Biochem Biophys Res Commun; 1985 Feb; 126(3):1242-50. PubMed ID: 3977914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of muscarinic cholinergic receptors on intact rat anterior pituitary cells.
    Mukherjee A; Snyder G; McCann SM
    Life Sci; 1980 Aug; 27(6):475-82. PubMed ID: 7412489
    [No Abstract]   [Full Text] [Related]  

  • 14. Guanine nucleotide binding sites, responsible for adenylate cyclase activation and carbamylcholine binding inhibition, show similar properties in rat heart membranes.
    Waelbroeck M; Robberecht P; Chatelain P; Christophe J
    J Cyclic Nucleotide Res; 1981; 7(3):173-85. PubMed ID: 7287969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SH-H subgroup of cardiac M2 receptors (M2 alpha) inhibits adenylate cyclase activity.
    Zhou XM; Mizushima A; Uchida S; Watanabe Y; Yoshida H
    Eur J Pharmacol; 1988 Sep; 154(3):229-36. PubMed ID: 3234478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The distribution of the muscarinic acetylcholine receptor antagonists, quinuclidinyl benzilate and quinuclidinyl benzilate methiodide (both tritiated), in rat, guinea pig, and rabbit.
    Gibson RE; Eckelman WC; Vieras F; Reba RC
    J Nucl Med; 1979 Aug; 20(8):865-70. PubMed ID: 541735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of cholinergic agents and local anesthetics on the kinetics of binding of tritiated toxin of Naja nigricollis to the cholinergic receptor].
    Weber M; Menez A; Fromageot P; Boquet P; Changeux JP
    C R Acad Hebd Seances Acad Sci D; 1972 Mar; 274(10):1575-8. PubMed ID: 4624958
    [No Abstract]   [Full Text] [Related]  

  • 18. Gallamine exerts biphasic allosteric effects at muscarinic receptors.
    Ellis J; Seidenberg M
    Mol Pharmacol; 1989 Feb; 35(2):173-6. PubMed ID: 2918854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibitory effect of gallamine on muscarinic receptors.
    Clark AL; Mitchelson F
    Br J Pharmacol; 1976 Nov; 58(3):323-31. PubMed ID: 990587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between gallamine and muscarinic receptors: allosterism and subpopulation specificity are separate phenomena.
    Ellis J; Seidenberg M
    Eur J Pharmacol; 1987 Nov; 144(1):39-44. PubMed ID: 3436360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.